KRMD Share Price Performance
US$5.78
1.48 (34.42%)
44.5% overvalued intrinsic discount
US$4.00
Fair Value
Price US$5.78
AnalystLowTarget US$4.00
Fair ValueUS$4.00
Share Pricen/a
KORU Medical Systems, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
KRMD Community Narratives
AN
Fair Value US$4 44.5% overvalued intrinsic discount
SCIg Therapy Adoption And Oncology Expansion Will Ultimately Disappoint Long-Term Expectations
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SCIg Therapy Adoption And Oncology Expansion Will Ultimately Disappoint Long-Term Expectations
Catalysts About KORU Medical Systems KORU Medical Systems develops and commercializes subcutaneous drug delivery systems, focused on infusions for immunoglobulin therapies and other specialty biologics. What are the underlying business or industry changes driving this perspective?Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$4
44.5% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
15.98% p.a.
Profit Margin
4.99%
Future PE
77.88x
Price in 2028
US$5
Trending Discussion
Recently Updated Narratives
AN
SCIg Therapy Adoption And Oncology Expansion Will Ultimately Disappoint Long-Term Expectations
Fair Value: US$4 44.5% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
KORU Medical Systems, Inc. Key Details
About KRMD
- Founded
- 1980
- Employees
- 80
- CEO
- WebsiteView website
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
